Craig Marshall - Non Executive Director

Craig brings more than two decades of senior leadership experience across advanced engineering, medical technology, and healthcare innovation. Most recently, he served as CEO of OrganOx, an Oxford University spin-out developing organ preservation technology. Under his leadership, OrganOx successfully commercialised its technology internationally, culminating in its acquisition by Terumo Corporation in a landmark $1.5 billion transaction in October 2025.

Prior to OrganOx, Craig served as Managing Director of Siemens Magnet Technology, an award-winning business responsible for the development and manufacture of magnet systems for MRI scanners. Earlier in his career, he held senior leadership positions at Oxford Instruments, Amersham plc, and GE Healthcare.